[go: up one dir, main page]
More Web Proxy on the site http://driver.im/

Zhang et al., 2018 - Google Patents

Expression of BC1 impairs spatial learning and memory in Alzheimer's disease via APP translation

Zhang et al., 2018

Document ID
3362707122387617379
Author
Zhang T
Pang P
Fang Z
Guo Y
Li H
Li X
Tian T
Yang X
Chen W
Shu S
Tang N
Wu J
Zhu H
Pei L
Liu D
Tian Q
Wang J
Wang L
Zhu L
Lu Y
Publication year
Publication venue
Molecular neurobiology

External Links

Snippet

Aggregation of amyloid-β (Aβ) peptides, which are the cleavage products of amyloid precursor protein (APP), is a major pathological hallmark in the brain of Alzheimer's disease (AD). Now, we know little about the roles of APP translation in the disease progression of …
Continue reading at link.springer.com (other versions)

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine, rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine, rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives, e.g. steroids
    • A61K31/57—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives, e.g. steroids substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane, progesterone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic, hydroximic acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/16—Amides, e.g. hydroxamic acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/1703—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • A61K38/1709—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals

Similar Documents

Publication Publication Date Title
Zhang et al. Expression of BC1 impairs spatial learning and memory in Alzheimer’s disease via APP translation
El Fatimy et al. MicroRNA-132 provides neuroprotection for tauopathies via multiple signaling pathways
Zheng et al. miR-135a-5p mediates memory and synaptic impairments via the Rock2/Adducin1 signaling pathway in a mouse model of Alzheimer’s disease
Park et al. Microglial MERTK eliminates phosphatidylserine‐displaying inhibitory post‐synapses
Shilling et al. Suppression of InsP3 receptor-mediated Ca2+ signaling alleviates mutant presenilin-linked familial Alzheimer's disease pathogenesis
Gadalla et al. MeCP2 and Rett syndrome: reversibility and potential avenues for therapy
Huang et al. A robust TDP-43 knock-in mouse model of ALS
Zhao et al. Appoptosin-mediated caspase cleavage of tau contributes to progressive supranuclear palsy pathogenesis
Brahmachari et al. Parkin interacting substrate zinc finger protein 746 is a pathological mediator in Parkinson’s disease
Su et al. Mutant α-synuclein overexpression mediates early proinflammatory activity
Qian et al. Down-regulated expression of microRNA-338-5p contributes to neuropathology in Alzheimer’s disease
Nakashima et al. Chronic lithium treatment decreases tau lesions by promoting ubiquitination in a mouse model of tauopathies
Song et al. Schizophrenia-like features in transgenic mice overexpressing human HO-1 in the astrocytic compartment
Zhang et al. TRIM11 protects against tauopathies and is down-regulated in Alzheimer’s disease
Zhang et al. Generation of a novel mouse model of Parkinson’s disease via targeted knockdown of glutamate transporter GLT-1 in the substantia nigra
Kondo et al. Tra2β, SF2/ASF and SRp30c modulate the function of an exonic splicing enhancer in exon 10 of tau pre‐mRNA
Keil et al. A short antisense oligonucleotide ameliorates symptoms of severe mouse models of spinal muscular atrophy
Sepp et al. The intellectual disability and schizophrenia associated transcription factor TCF4 is regulated by neuronal activity and protein kinase A
Calafate et al. Early alterations in the MCH system link aberrant neuronal activity and sleep disturbances in a mouse model of Alzheimer’s disease
Liu et al. Silencing PP2A inhibitor by lenti-shRNA interference ameliorates neuropathologies and memory deficits in tg2576 mice
Mende et al. Deficiency of the splicing factor Sfrs10 results in early embryonic lethality in mice and has no impact on full-length SMN/Smn splicing
Cheng et al. Triggering receptor expressed on myeloid cells-2 (TREM2) interacts with colony-stimulating factor 1 receptor (CSF1R) but is not necessary for CSF1/CSF1R-mediated microglial survival
Gabriele et al. Knockdown of amyloid precursor protein: biological consequences and clinical opportunities
JP2022510341A (en) How to detect, prevent, recover and treat neurological disorders
Milagre et al. Transcriptional regulation of the human CYP46A1 brain‐specific expression by Sp transcription factors